• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨氏单位:一种有前途的用于诊断良性前列腺增生的无创工具。

Hounsfield units: A promising non-invasive tool for diagnosing benign prostatic hyperplasia.

机构信息

Universty of Health and Science Sultan Abdulhamid Han Training and Research Hospital Istanbul, Estambul, Turkey.

Universty of Health and Science Sultan Abdulhamid Han Training and Research Hospital Istanbul, Estambul, Turkey.

出版信息

Actas Urol Esp (Engl Ed). 2022 Sep;46(7):407-412. doi: 10.1016/j.acuroe.2021.11.006. Epub 2022 Jun 28.

DOI:10.1016/j.acuroe.2021.11.006
PMID:35778339
Abstract

OBJECTIVE

The clinical symptoms in benign prostatic hyperplasia (BPH) are directly proportional to prostate volume. We aimed to show whom and when to intervene in a noninvasive way, correlating the patient's subjective symptoms with objective diagnostic tools.

MATERIAL AND METHOD

International Prostate Symptom Score (IPSS) was evaluated in patients who consulted the urology outpatient clinic for the first time with lower urinary tract symptoms (LUTS). Subsequently, PSA, urea, creatinine, complete urinalysis, uroflowmetry, urinary tract ultrasound and non-contrast lower abdominal computed tomography (CT) examinations were requested. Prostate central (transitional zone) zone and peripheral zone HU scores, prostatic urethral length and bladder wall Hounsfield units (HU) scores were recorded by using computed tomography (CT). The ellipsoid formula was used for ultrasonographic and tomographic measurements of prostate size (anteroposterior diameter × transverse diameter × longitudinal diameter × 0.52).

RESULTS

A statistically significant negative correlation was found between the prostate peripheral zone/central zone HU ratio and the maximum flow rate measured in the uroflowmetry test.

CONCLUSION

This is the first study in the literature to evaluate the correlation between voiding parameters such as Qmax, Qave and IPSS scores, and prostate and bladder wall HU scores obtained by computed tomography examination in BPH patients. A significant relationship has been detected between the peripheral zone/central zone HU ratio and Q max. Additional studies with larger patient populations could better clarify the contribution of HU in the diagnosis of BPH and treatment decision making of these patients.

摘要

目的

良性前列腺增生(BPH)的临床症状与前列腺体积成正比。我们旨在通过将患者的主观症状与客观诊断工具相关联,以非侵入性的方式展示何时以及向谁进行干预。

材料和方法

首次因下尿路症状(LUTS)到泌尿科门诊就诊的患者,评估国际前列腺症状评分(IPSS)。随后,要求进行 PSA、尿素、肌酐、全尿分析、尿流率、尿路超声和非对比下腹部计算机断层扫描(CT)检查。通过 CT 记录前列腺中央(移行区)区和外周区 HU 评分、前列腺尿道长度和膀胱壁 HU 评分。使用超声和 CT 测量前列腺体积(前后径×横径×长径×0.52)。

结果

在尿流率测试中,前列腺外周区/中央区 HU 比值与最大流量之间存在统计学显著负相关。

结论

这是文献中第一项评估 BPH 患者的排尿参数(如最大流量 Qmax、平均流量 Qave 和 IPSS 评分)与通过 CT 检查获得的前列腺和膀胱壁 HU 评分之间相关性的研究。在外周区/中央区 HU 比值与 Qmax 之间检测到显著相关性。更大的患者人群的进一步研究可以更好地阐明 HU 在 BPH 诊断和这些患者的治疗决策中的作用。

相似文献

1
Hounsfield units: A promising non-invasive tool for diagnosing benign prostatic hyperplasia.亨氏单位:一种有前途的用于诊断良性前列腺增生的无创工具。
Actas Urol Esp (Engl Ed). 2022 Sep;46(7):407-412. doi: 10.1016/j.acuroe.2021.11.006. Epub 2022 Jun 28.
2
[Ultrasound indicators of the prostate, urinary bladder and uroflowmetry parameters in the diagnosis of infravesical obstruction in men with benign prostatic hyperplasia].[前列腺、膀胱超声指标及尿流率参数在良性前列腺增生男性膀胱颈梗阻诊断中的应用]
Urologiia. 2017 Oct(5):9-14. doi: 10.18565/urology.2017.5.9-14.
3
Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia.前列腺解剖学参数与提示良性前列腺增生的临床特征相关。
Asian J Androl. 2021 Jan-Feb;23(1):64-68. doi: 10.4103/aja.aja_47_20.
4
Clinical significance of peripheral zone thickness in men with lower urinary tract symptoms/benign prostatic hyperplasia.下尿路症状/良性前列腺增生男性外周带厚度的临床意义
BJU Int. 2016 Feb;117(2):316-22. doi: 10.1111/bju.13130. Epub 2015 Jun 3.
5
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.前列腺内注射肉毒毒素 A 治疗良性前列腺增生所致下尿路症状(LUTS)男性患者的患者报告结局:一项前瞻性单臂队列研究的 3 个月结果。
BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19.
6
Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).他达拉非改善提示良性前列腺增生的下尿路症状患者的症状、勃起功能及生活质量(KYU-PRO研究)。
Low Urin Tract Symptoms. 2018 Jan;10(1):76-83. doi: 10.1111/luts.12143. Epub 2016 Nov 5.
7
Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.度他雄胺联合坦索罗辛或单药治疗良性前列腺增生伴下尿路症状患者后国际前列腺症状评分变化的基线变量影响:CombAT 研究 4 年结果。
BJU Int. 2014 Apr;113(4):623-35. doi: 10.1111/bju.12500. Epub 2014 Jan 9.
8
The impact of the bladder wall thickness on the outcome of the medical treatment using alpha-blocker of BPH patients with LUTS.膀胱壁厚度对使用α受体阻滞剂治疗伴有下尿路症状的良性前列腺增生症患者的疗效的影响。
Aging Male. 2015 Jun;18(2):89-92. doi: 10.3109/13685538.2014.967672. Epub 2014 Oct 8.
9
Temporary implantable nitinol device (TIND): a novel, minimally invasive treatment for relief of lower urinary tract symptoms (LUTS) related to benign prostatic hyperplasia (BPH): feasibility, safety and functional results at 1 year of follow-up.临时植入式镍钛诺装置(TIND):一种用于缓解与良性前列腺增生(BPH)相关的下尿路症状(LUTS)的新型微创治疗方法:随访1年的可行性、安全性和功能结果
BJU Int. 2015 Aug;116(2):278-87. doi: 10.1111/bju.12982. Epub 2015 Mar 7.
10
[Ningmitai Capsules relieve lower urinary tract symptoms in patients with benign prostatic hyperplasia : A short-term clinical observation].宁米泰胶囊缓解良性前列腺增生患者下尿路症状:一项短期临床观察
Zhonghua Nan Ke Xue. 2018;24(1):72-77.